The brand is explicit that this is a starting price: "your starting cost depends on the care option recommended for you," and "final pricing may vary depending on the treatment path selected through clinical review." In plain terms, the number in the ad is a floor, not a fixed quote - what you're actually billed depends on what a provider recommends after reviewing your intake
Pharmaceutical companies invest billions in research, development, and clinical trials to bring these drugs to market
Any decision to use GLP-1s in this context requires close collaboration between your full treatment team, including specialists who understand both your medical condition and your eating disorder history
That's where MeAgain's GLP-1 app becomes genuinely useful
Never massage the injection site, as this can increase absorption speed and potentially destabilize dose timing
weight loss accelerates 72w 72 Weeks Average 20.9% body weight lost at 15 mg dose in SURMOUNT-1 trial Eligibility Who Qualifies BMI of 30 or higher (obesity classification) BMI of 27 or higher with a weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnea No personal or family history of medullary thyroid cancer No history of multiple endocrine neoplasia syndrome type 2 Not currently pregnant, planning pregnancy, or breastfeeding No prior severe allergic reaction to tirzepatide Your Program Common Side Effects Most side effects are gastrointestinal, mild to moderate in severity, and tend to resolve as your body adjusts during the first several weeks